MedLife opens new hyper-clinic in Constanta, plans to open four more across the country next year

Newsroom 12/11/2014 | 12:21

MedLife opened a new hyper-clinic in Constanta, following a EUR 2 million investment. The project was developed with financing granted by Banca Comerciala Romana BCR.

The new unit, which stands on a 1,300 sqm surface, offers medical services covering 22 specialties and includes an imaging department with an RMN 3T machine. The unit also includes an excellence center in esthetic dermatology.

“Constanta is one of the strategic cities in our development and expansion plan, which can be seen from the investments we made so far here. We bought a laboratory, we opened a large clinic, we developed an excellence center in esthetic dermatology, we invested in opening a top imaging department and last but not least we opened our own pharmacy,” said Mihai Marcu, the president of the MedLife board of administration.

After opening this year clinics in Galati, Iasi and Constanta, the company says it plans to open at least four new clinics in other large cities across the country. MedLife had 1.3 million patients at the end of June of this year.

Medical services provider MedLife reported a turnover of EUR 38.3 million for the first six months of 2014, up 12 percent on the similar period of last year. According to the company, the results are in line with its business targets, and the growth rhythm of the company is above the 8-9 percent one posted by the private medical services market.

MedLife has been active on the local market since 1996. The company owns 11 hyper clinics in Bucharest, Timisoara, Brasov, Arad, Galati and Iasi; 8 laboratories; 6 hospitals in Bucharest, Brasov and Arad, out of which a pediatrics one, an orthopedy one and an obstetrics one; 3 maternities in Bucharest and throughout the country; 9 excellence centers with dedicated specializations; and 7 pharmacies.

 

 

 

Close ×

We use cookies for keeping our website reliable and secure, personalising content and ads, providing social media features and to analyse how our website is used.

Accept & continue